The Division of Infectious Diseases conducts cutting-edge clinical and laboratory research that seeks to translate novel scientific findings into new approaches for the prevention, diagnosis and treatment of infectious disease. The Division has played an important role in advances that have shed light on HIV and impacted the clinical care for patients with HIV/AIDS. Building on that tradition, the Division seeks to allow the gains made in genomics, proteomics, and bioinformatics research to improve the quality of health care to reach all populations, particularly those who bear the greatest burden of infectious diseases.
The division has 17 NIH-funded investigators, as well as an additional faculty member funded by other grant mechanisms. It receives nearly $10 million in annual biomedical research grants from the NIH to support our work. Research initiatives in our Division cut across scientific disciplines and institutions. These projects aim to uncover:
- HIV pathogenesis
- Early innate immune response to RNA virus infection
- Genetic basis of infectious disease
- HIV-Hepatitis co-infection
- Molecular pathogenesis of P. aeruginosa disease
- Health care epidemiology
The Drucker Laboratories, located on the 9th floor of the Robert H. Lurie Medical Research Center, provide work areas for contemporary proteomic and genomic technologies targeted for research of infectious diseases. State-of-the-art core facilities, which contain the most advanced equipment available, include a 2,000-square-foot BSL-3 suite, several Tissue Culture labs, a Flow Cytometer room, Confocal Microscopy, Central Prep Lab and an Analytical Lab.